BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1819809)

  • 1. [Antibodies to measles virus in blood sera of individuals who were not verified as having been infected with the virus (years 1984-1989)].
    Gut W; Litwińska B
    Przegl Epidemiol; 1991; 45(3):147-56. PubMed ID: 1819809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the cause of increased measles incidence in Xinjiang, China in 2004.
    Yu X; Wang S; Guan J; Mahemuti ; Purhati ; Gou A; Liu Q; Jin X; Ghildyal R
    Pediatr Infect Dis J; 2007 Jun; 26(6):513-8. PubMed ID: 17529869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.
    Hickman CJ; Hyde TB; Sowers SB; Mercader S; McGrew M; Williams NJ; Beeler JA; Audet S; Kiehl B; Nandy R; Tamin A; Bellini WJ
    J Infect Dis; 2011 Jul; 204 Suppl 1():S549-58. PubMed ID: 21666212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 8. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G; Petersen I; Mordhorst CH
    Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with a measles vaccine manufactured in India.
    Shaikh N; Raut SK; Bedekar SS; Phadke MA; Banerjee K
    Indian Pediatr; 1992 Jul; 29(7):883-7. PubMed ID: 1428138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
    East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the immunization effect of measles vaccine by capture-EIA].
    Fang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles immunity and response to revaccination of a young adult population in Israel.
    Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
    J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
    Lin M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):138-40. PubMed ID: 1423535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.